Article
Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations.
Paediatric drugs - 1 Jan 2010
Yoshimi Ayami, Kojima Seiji, Hirano Naoto
Abstract excerpt
Juvenile myelomonocytic leukemia (JMML) is a rare hematopoietic malignancy of early childhood with features characteristic of both myelodysplastic and myeloproliferative disorders. Recent studies clearly show that the deregulated activation of the RAS signaling pathway plays a central role in the pathogenesis of JMML. Somatic defects in either RAS, PTPN11 or NF1 genes involved in this pathway are detected in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
